Study of correlation between polymorphism of ST6GALNAC2 and susceptibility to IgA nephropathy

Lu,Chen; Li,Wen-Lan; Ma,Yi‑Ran

doi:10.3892/etm.2015.2404

Study of correlation between polymorphism of ST6GALNAC2 and susceptibility to IgA nephropathy

Authors:
- Chen Lu
- Wen-Lan Li
- Yi‑Ran Ma
View Affiliations

Affiliations: Nephrology Department, People's Hospital of Xinjiang Uyghur Autonomous Region, Urumqi, Xinjiang 830000, P.R. China, Medical Department, People's Hospital of Xinjiang Uyghur Autonomous Region, Urumqi, Xinjiang 830000, P.R. China
Published online on: April 3, 2015 https://doi.org/10.3892/etm.2015.2404
Pages: 2127-2132

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to explore the correlation between single nucleotide polymorphisms (SNPs) rs3840858 and rs2304921 in a specific α-2,6 sialyltransferase gene, ST6GALNAC2, and the susceptibility to immunoglobulin (IgA) nephropathy (IgAN). The distributions of genotypes of SNPs rs3840858 and rs2304921 in ST6GALNAC2 were detected by direct sequencing. The distributions of the genotype and allele frequencies of rs3840858 in patients with IgAN were significantly different from those in the control group (genotypes, P=0.001; alleles, P=0.001). The DI genotype ratio (17.8%) in the IgAN group was higher than that in the control group (5.6%) and the I allele frequency (8.9%) in the IgAN group was higher than that in the control group (2.8%). Univariate logistic regression analysis indicated that rs3840858 polymorphism is a risk factor of IgAN (P=0.001). The risk of developing IgAN in individuals who carried the DI genotype was 3‑fold higher than that in individuals who carried the DD genotype [odds ratio (OR)=3.676, 95% confidence interval (CI)=1.284-10.519], and the risk of developing IgAN in individuals who carried the I allele was higher than that in individuals who carried the D allele (OR=3.415, 95% CI=1.223-9.531). The distributions of the genotype (AA, AG and GG) and allele (A and G) frequencies of rs2304921 did not have a statistically significant difference between patients with IgAN and those without (P>0.05). The SNP rs3840858 in the ST6GALNAC2 gene may be associated with the risk of developing IgAN in the population studied; however, polymorphism of rs2304921 appears to be irrelevant to the risk of developing IgAN in this population.

View Figures

View References

1	Zhang YQ: Pathological and clinical analysis of IgA nephropathy. Zhong Guo Xian Dai Yi Yao Za Zhi. 17:722010.[(In Chinese)].
2	Yang DS, Luo CG, Jiang WM, et al: Observation of efficacy of combination therapy with Leflunomide and hormone on IgA nephropathy. Zhong Guo Xian Dai Yi Yao Za Zhi. 17:74–75. 2010.[(In Chinese)].
3	Li LS and Liu ZH: Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int. 66:920–923. 2004. View Article : Google Scholar : PubMed/NCBI
4	Barratt J and Feehally J: IgA nephropathy. J Am Soc Nephrol. 16:2088–2097. 2005. View Article : Google Scholar : PubMed/NCBI
5	Chen XM and Xie YS: Attach importance to basic and clinical research on the postponement of progression of IgA nephropathy. Chin J Nephrol. 20:235–237. 2004.[(In Chinese)].
6	Yu XQ, Li M, Zhang H, Low HQ, Wei X, Wang JQ, Sun LD, Sim KS, Li Y, et al: A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy. Nat Genet. 44:178–182. 2011. View Article : Google Scholar : PubMed/NCBI
7	Yu HH, Chu KH, Yang YH, et al: Genetics and immunopathogenesis of IgA nephropathy. Clin Rev Allergy Immunol. 41:198–213. 2011. View Article : Google Scholar : PubMed/NCBI
8	Kiryluk K, Julian BA, Wyatt RT, et al: Genetic studies of IgA nephropathy: past, present, and future. Pediatr Nephrol. 25:2257–2268. 2010. View Article : Google Scholar : PubMed/NCBI
9	Wang H, Sui W, Xue W, Wu J, Chen J and Dai Y: Univariate and multiple linear regression analyses for 23 single nucleotide polymorphisms in 14 genes predisposing to chronic glomerular diseases and IgA nephropathy in Han Chinese. Saudi J Kidney Dis Transpl. 25:992–997. 2014.PubMed/NCBI
10	Xu R, Feng S, Li Z, Fu Y, et al: Polymorphism of DEFA hinese Han population with IgA nephropathy. Hum Genet. 133:1299–1309. 2014. View Article : Google Scholar : PubMed/NCBI
11	Mao S, Ren X, Huang S and Zhang A: Association of megsin 2093C/T, 2180C/T and C25663G gene polymorphism with the risk of IgA nephropathy. Ren Fail. 36:817–822. 2014. View Article : Google Scholar : PubMed/NCBI
12	Li GS, Zhu L, Zhang H, et al: Variants of the ST6GALNAC2 promoter influence transcriptional activity and contribute to genetic susceptibility to IgA nephropathy. Hum Mutat. 28:950–957. 2007. View Article : Google Scholar : PubMed/NCBI
13	Zou WZ: Guidance on renal biopsy pathologic diagnostic criteria. Chin J Nephrol. 17:270–275. 2001.[(In Chinese)].
14	Zhu B, Zhu CF, Lin Y, Perkovic V, et al: Clinical characteristics of IgA nephropathy associated with low complement 4 levels. Ren Fail. 1–9. Dec 24–2014.(Epub ahead of print).
15	Shimozato S, Hiki Y, Odani H, Takahashi K, Yamamoto K and Sugiyama S: Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy. Nephrol Dial Transplant. 23:1931–1939. 2008. View Article : Google Scholar : PubMed/NCBI
16	Gharavi AG, Moldoveanu Z, Wyatt RJ, Barker CV, Woodford SY, et al: Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol. 19:1008–1014. 2008. View Article : Google Scholar : PubMed/NCBI
17	Lin XJ, Ding JX, Zhu L, et al: Aberrant galactosylation of IgA1 is involved in the genetic susceptibility of Chinese patients with IgA nephropathy. Nephrol Dial Transplant. 24:3372–3375. 2009. View Article : Google Scholar : PubMed/NCBI
18	Gharavi AG, Moldoveanu Z, Wyatt RJ, et al: Aberrant IgAl glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol. 19:1008–1014. 2008. View Article : Google Scholar : PubMed/NCBI
19	Patsos G, Hebbe-Viton V, Robbe-Masselot C, et al: O-glycan inhibitors generate aryl-glycans, induce apoptosis and lead to growth inhibition in colorectal cancer cell lines. Glycobiology. 19:382–398. 2009. View Article : Google Scholar : PubMed/NCBI
20	Ding JX, Xu LX, Lv JC, et al: Aberrant sialylation of serum IgA1 was associated with prognosis of patients with IgA nephropathy. Clin Immunol. 125:268–274. 2007. View Article : Google Scholar : PubMed/NCBI
21	Zhu L, Ding JX, Lv JC, et al: Expression of ST6GALNAC2 gene in B lymphocytes is influenced in Epstein-Barr virus transformation. Chinese Journal of Nephrology. 24:130–133. 2008.[(In Chinese)].